164 results
Page 8 of 9
6-K
EX-99.1
hdmo2lhkm8sx tkmc
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.2
o76afh3fp22ql2 mjie0
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
uosj1te
17 Jul 14
RepliCel Appoints Brooke Hurford as Corporate Secretary and Director, Finance
12:00am
6-K
EX-99.1
elhe6
23 Jun 14
RepliCel Retains O&M Partners to Coordinate North American Focused Investor Marketing Campaign
12:00am
6-K
EX-99.1
nyb0irn385
18 Jun 14
RepliCel Life Sciences Announces Closing of Third and Final Tranche of
12:00am
6-K
EX-99.1
haunt1wy4
6 Jun 14
Replicel Life Sciences Inc. 6-K
12:00am
6-K
EX-99.2
yp7i lp1xc2n
29 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
ikm47 yfjghzn
29 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
q7xfvkt6luv
22 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
kcvp06su
22 May 14
Replicel Life Sciences Inc. Form 6-K
12:00am
6-K
EX-99.2
i6cx2 ybw4mtkcbs
18 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.1
81nz3hov
18 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.1
8ha d8p60fbg0z5
27 Feb 14
RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress
12:00am
6-K
EX-99.1
ejnsxq3 n71sb9p
27 Feb 14
Replicel Life Sciences Inc. Form 6-K
12:00am
6-K
EX-99
83ti89zazsp7g7lku0
9 Jan 14
RepliCel to Commence Trading on the TSX Venture Exchange
12:00am
6-K
5y5sitbumjdly68w8y
20 Nov 13
Current report (foreign)
12:00am
6-K
EX-99.1
f0zrstzgh 4cb7fk
28 Aug 13
Current report (foreign)
12:00am
6-K
EX-99.2
mh60ewkz3uqpacyu2d9l
12 Jul 13
Current report (foreign)
12:00am
6-K
EX-99.1
ug6qe1dzxx
12 Jul 13
Current report (foreign)
12:00am